HAL vs NEUP · P/E 9.3, $19.05B cap vs rev $15.0M
Halliburton Company (HAL) versus Neuphoria Therapeutics Inc (NEUP) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported NEUP revenue for 2025-03-31 was $15.0M. Net income was $11.3M. NEUP currently screens at market cap $23.6M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. NEUP currently screens at market cap $23.6M.
Not investment advice. Open the HAL and NEUP stock pages for the full models.
Not investment advice.